Sublayer‐ and pathway‐specific control of CA1 input processing by VIP interneurons Authors: Parisa Iloun, Jordan Grenier, Felix Veillette, Lisa Topolnik Published: 2026 ABSTRACT AbstractVasoactive intestinal peptide‐expressing interneurons (VIP‐INs) are prominent regulators of inhibition in hippocampal circuits, yet how their dual inhibitory and disinhibitory actions shape pathway‐specific processing across pyramidal cell sublayers remains unclear. Here, we combined pathway‐specific electrophysiology with optogenetic and chemogenetic manipulations and semi‐quantitative immunohistochemistry to examine how VIP‐INs control excitation–inhibition balance in superficial (sPCs) and deep (dPCs) CA1 pyramidal neurons. Optogenetic activation revealed direct inhibitory synaptic input from VIP‐INs onto both sublayers with comparable strength, despite distinct bouton composition, with cannabinoid receptor‐positive VIP terminals enriched in superficial strata and cannabinoid receptor‐negative boutons more prominent in deep layers. Chemogenetic silencing of VIP‐INs uncovered sublayer‐ and pathway‐specific disinhibitory motifs. During Schaffer collateral activation, VIP‐INs preferentially reduced inhibition onto dPCs, indicating selective disinhibitory control of deep pyramidal neurons. In contrast, during temporoammonic input processing, VIP‐IN silencing increased excitatory responses in sPCs while enhancing inhibitory drive in dPCs, consistent with differential regulation of distal dendritic integration. Selective optogenetic activation of lateral entorhinal cortex inputs further revealed a shared disinhibitory role of VIP‐INs, as silencing increased inhibitory synaptic responses in both sublayers, with a stronger effect in sPCs. Together, these findings identify VIP‐INs as pathway‐ and sublayer‐specific modulators that dynamically gate excitation–inhibition balance in CA1, supporting parallel processing of hippocampal inputs rather than uniform network disinhibition. Key points Interneurons that release vasoactive intestinal peptide (VIP cells) are often viewed as simple disinhibitory ‘gatekeepers’, but their role in regulating superficial and deep CA1 pyramidal cell sublayers along the hippocampal radial axis has remained unclear.We show that VIP cells regulate excitation and inhibition through distinct circuit motifs linked to superficial and deep pyramidal neurons rather than through uniform network disinhibition.VIP cells provide direct inhibition to pyramidal neurons while also suppressing other inhibitory cells, revealing a dual mechanism that depends on the active input pathway.During Schaffer collateral input, VIP cells preferentially reduce inhibition of deep neurons, whereas during temporoammonic input, including lateral entorhinal cortex projections, they shape dendritic excitation and inhibition in a sublayer‐specific manner.These findings identify VIP cells as pathway‐ and layer‐specific modulators that help the hippocampus balance stable and flexible information processing. Introduction Across cortical regions, vasoactive intestinal peptide‐expressing interneurons (VIP‐INs) constitute a diverse class of GABAergic cells that play a central role in dynamically regulating excitation–inhibition balance through both disinhibitory and direct inhibitory mechanisms (Guet‐McCreight et al., 2020; Kullander & Topolnik, 2021; Topolnik & Tamboli, 2022). In the hippocampal CA1 area, most VIP‐INs belong to the interneuron‐specific (IS) class and preferentially target other inhibitory neurons, yet they also form synapses onto pyramidal cells (PCs), highlighting their dual functional potential (Acsády et al., 1996; Francavilla et al., 2018; Tyan et al., 2014). Morphological, molecular and transcriptomic studies distinguish several VIP‐IN subtypes in CA1, including VIP/cholecystokinin (CCK)‐coexpressing basket cells (VIP‐BCs), IS‐2 and IS‐3 cells (Acsády et al., 1996; Chamberland et al., 2010; Luo et al., 2020; Tyan et al., 2014), as well as long‐range projecting VIP neurons (Francavilla et al., 2018; Luo et al., 2019). These subtypes differ in laminar position, axonal targeting and postsynaptic selectivity. The dominant population comprises VIP/calretinin‐coexpressing IS‐3 cells (Luo et al., 2020; Magnin et al., 2019; Tamboli et al., 2024), which prominently innervate dendrite‐targeting interneurons such as oriens–lacunosum moleculare (OLM) and bistratified cells (Francavilla et al., 2018; Tyan et al., 2014). By inhibiting these interneurons, IS‐3 cells can mediate compartment‐specific disinhibition of PC dendrites (Bilash et al., 2023; Francavilla et al., 2015), thereby shaping the integration of specific excitatory inputs. VIP‐IN recruitment is strongly state‐dependent. In vivo optophysiological recordings and two‐photon imaging demonstrated that most IS VIP‐INs are preferentially active during locomotion and theta oscillations, while remaining largely silent during sharp‐wave ripples (Geiller et al., 2020; Luo et al., 2020; Turi et al., 2019; Valero et al., 2025). In contrast, VIP‐BC and long‐range projecting VIP populations show complementary recruitment during quiescent states (Francavilla et al., 2018; Geiller et al., 2020), suggesting VIP‐IN functional specialization across behavioural contexts. Consistent with this view, perturbation of VIP‐IN activity impairs spatial learning, goal‐directed navigation, novelty encoding and recognition memory (Magnin et al., 2019; Tamboli et al., 2024; Turi et al., 2019), supporting a role for VIP‐INs in memory encoding and contextual modulation rather than baseline excitability control. While VIP‐INs exert powerful, state‐dependent control over hippocampal circuit dynamics, the functional impact of this modulation depends not only on the identity of their postsynaptic targets but also on how these targets are embedded within local inhibitory–excitatory microcircuits. In CA1, PCs exhibit pronounced heterogeneity along the dorsoventral, proximodistal and radial axes (Cembrowski & Spruston, 2019; Soltesz & Losonczy, 2018), raising the possibility that VIP‐INs are differentially embedded within distinct PC subnetworks. Radially, PCs segregate into superficial (sPCs) and deep (dPCs) sublayers, a division rooted in embryonic birthdate and maintained across development (Cavalieri et al., 2021; Huszár et al., 2022). These subtypes differ in transcriptomic profiles, dendritic morphology, intrinsic excitability, afferent connectivity and spatial coding strategies (Cembrowski et al., 2016; Danielson et al., 2016; Geiller et al., 2017; Kohara et al., 2014; Masurkar et al., 2017; 2020; Mizuseki et al., 2011; Navas‐Olive et al., 2020; Sharif et al., 2021; Stark et al., 2014). Importantly, this structural and functional diversity is mirrored by subtype‐specific inhibitory circuit motifs. At the perisomatic level, dPCs receive stronger inhibition from parvalbumin‐expressing basket cells (PV‐BCs; Hanson et al., 2025; Lee et al., 2014), whereas sPCs are preferentially innervated by cannabinoid receptor 1 (CB1R)‐positive boutons originating from CCK‐expressing basket cells (Valero et al., 2015; but see Lee et al., 2014). In addition, recent work revealed sublayer‐specific innervation by dendrite‐targeting interneurons, with Chrna‐2‐expressing OLM cells providing stronger inhibition to dPCs, and bistratified cells preferentially targeting sPCs (Johantges et al., 2025). Together, these findings point to the existence of distinct inhibitory microcircuits that sculpt the computational roles of sPCs and dPCs. A key unresolved question is how VIP‐INs fit into this subtype‐specific circuit architecture. In the present study, we address this gap by examining how VIP‐INs regulate excitation–inhibition balance in CA1 sPCs and dPCs during pathway‐specific activation of Schaffer collateral (SC) and temporoammonic (TA) inputs, with a focus on lateral entorhinal cortex (LEC) to CA1 projection. Using a combination of optogenetic, chemogenetic and electrophysiological approaches, we identify sublayer‐ and pathway‐specific VIP‐IN microcircuit motifs that selectively shape inhibitory gain under high‐activity conditions. Our findings demonstrate that VIP‐INs are not global modulators of CA1 input integration but instead provide targeted, state‐dependent control over distinct PC populations and afferent pathways, refining current models of inhibitory regulation in hippocampal computations and memory processing. Materials and methods Ethical approval All animal experiments were approved by and carried out in accordance with the regulations and recommendations of the Animal Facility of the Université Laval (protocols #2015‐097, 2019–045 and 2022‐1160) and the Canadian Council of Animal Care. All efforts were made to minimize animal suffering and to reduce the number of animals used. Experimental animals Experiments were performed in three mouse lines: Viptm1(cre)Zjh/J (VIP‐Cre) (Jackson Laboratory, stock #010908), the double transgenic Vip‐Cre;Ai9 mice obtained by breeding B6.Cg‐Gt(ROSA)26Sortm9(CAG‐tdTomato)Hze/J (Jackson Laboratory, stock #007909) with Viptm1(cre)Zjh/J, and the double transgenic Vip‐Cre;Ai32 mice produced by breeding the ChR2 reporter line B6.Cg‐Gt(ROSA)26Sortm32(CAG‐COP4*H134R/EYFP)Hze/J (Jackson Laboratory, stock #012569) with Viptm1(cre)Zjh/J. Mice of both sexes aged P30–100 were used. Animals were group‐housed (up to four per cage) under a 12 h light/dark cycle with ad libitum access to food and water. Patch‐clamp recordings in hippocampal slices Mice were deeply anaesthetized with ketamine‐xylazine (100 mg/kg and 10 mg/kg, intraperitoneal), perfused intracardially with ice‐cold sucrose‐based solution (containing the following in mm: 250 sucrose, 2 KCl, 1.25 NaH2PO4, 26 NaHCO3, 7 MgSO4, 0.5 CaCl2 and 10 glucose; pH 7.4, 310–320 mOsm/L) and decapitated. Acute transverse hippocampal slices (300 µm thick) were prepared from dorsal to intermediate regions using standard procedures (Camiré et al., 2018; Francavilla et al., 2020). Slices were transferred to a recording chamber perfused continuously (2 mL/min) with oxygenated artificial cerebrospinal fluid (aCSF; pH 7.4; 300–310 mOsm) heated to 30–33°C and containing: NaCl (124 mm), KCl (2.5 mm), NaH2PO4 (1.25 mm), MgCl2 (2 mm), NaHCO3 (26 mm), glucose (25 mm), CaCl2 (2 mm). Patch pipettes (3.5–5.5 MΩ) were filled with either a K+‐based internal solution (for current‐clamp recordings) containing: KMeSO4 (130 mm), MgCl2 (2 mm), diNa‐phosphocreatine (10 mm), ATP‐Tris (4 mm), GTP‐Na (0.4 mm) and 0.3% biocytin (Sigma), pH 7.2–7.3; 280–290 mOsm; or a Cs+‐based solution (for voltage‐clamp recordings) composed of: CsMeSO4 (130 mm), CsCl (2 mm), diNa‐phosphocreatine (10 mm), ATP‐Tris (4 mm), GTP‐Na (0.4 mm), biocytin (0.3%) and QX‐314 (1 mm), pH 7.2–7.3; 280–290 mOsm. In some experiments, high‐chloride K‐based internal solution containing K‐gluconate (70 mm) and KCl (70 mm) was used (Bartos et al., 2001). Whole‐cell recordings from CA1 PCs were obtained under physiological conditions with GABAergic inhibition kept intact, using a MultiClamp 700B amplifier and Clampex 10.5 software (Molecular Devices). Electrophysiological signals were filtered at 2–3 kHz and digitized at 10 kHz via a Digidata 1550A digitizer. Series resistance was monitored throughout and recordings were discontinued if resistance changed by more than 15%. To characterize membrane properties of PCs (Fig. 1E–G ), 20 current steps with 20 pA increments starting from –200 pA were injected. For SC stimulation, a bipolar theta‐glass microelectrode (tip diameter: 2–3 µm, Sutter Instruments) was placed in the CA1 stratum radiatum (RAD). For stimulation of the TA pathway, the microelectrode was placed in the stratum lacunosum‐moleculare (SLM). Recordings were performed in current‐clamp mode at membrane potential between –68 and –72 mV; resting membrane potential at break‐in was typically −80 to −88 mV (junction potential corrected). Stimulation intensity was standardized across cells by normalizing to the minimal stimulation producing the minimal postsynaptic response in a given cell. After detecting the minimal response, intensity was increased in four successive steps of 50%, resulting in five points of measurements for input–output curves. Electrical stimuli (0.1 ms) were applied every 15 s. The IPSP reversal potential was determined by clamping cells at different V m levels in aCSF containing NBQX (12.5 µm, Abcam Biochemicals, ab120046) and D,L‐AP5 (100 µm, Abcam Biochemicals, ab120271) to pharmacologically isolate IPSPs (Fig. 3). In some experiments, picrotoxine (50 µm, TCI, C0275‐16) or CGP‐55845 hydrochloride (2 µm, Hello Bio, HB0960) were applied in the bath to test the contribution of the GABAA or GABAB receptor components, respectively, to light‐evoked IPSCs in PCs. Membrane and morphological properties of sPCs and dPCs A, representative confocal images of the dorsal hippocampal CA1 pyramidal layer immunolabeled for Wfs1 (red) and calbindin (CB; green). B, confocal image (left) and corresponding anatomical reconstructions (right) of biocytin‐labelled sPCs (blue) and dPCs (brown) recorded in the same slice. C, distribution of the dorsal CA1 pyramidal layer thickness based on Wfs1 labelling (grey), with the superficial sublayer marked by CB (blue). The dotted line indicates the average thickness of the superficial sublayer. D, histograms showing the soma distance from the PYR–RAD border for recorded sPCs (blue; n = 28) and dPCs (brown; n = 22). E, voltage traces from sPCs (blue) and dPCs (brown) in response to hyperpolarizing and depolarizing current steps (bottom). F, summary data comparing resting membrane potential (n = 56 cells: 31 sPCs, 25 dPCs; N = 30 mice: 17F, 13M; P = 0.0746, Mann–Whitney test), input resistance (n = 63 cells: 33 sPCs, 30 dPCs; N = 33 mice: 17F, 16M; P = 0.0002, Mann–Whitney test) and membrane capacitance (n = 62 cells: 29 sPCs, 33 dPCs; N = 33 mice: 16F, 17M; P = 0.104, unpaired t test). G, differences in rheobase (n = 60 cells: 30 sPCs, 30 dPCs; N = 28 mice: 14F, 14M; P = 0.0062, Mann–Whitney test) and firing rate (n = 22 cells: 11 sPCs, 11 dPCs; N = 16 mice: 8F, 8M; P < 0.0001, two‐way ANOVA). H, morphological properties comparisons: soma area (n = 19 cells: 10 sPCs, 9 dPCs; N = 16 mice: 6F, 10M; P = 0.1293, unpaired t test), total apical dendrite surface (P = 0.0127), dendritic length (P = 0.0009), and apical dendrite length in RAD (P < 0.0001) vs. SLM (P = 0.3209; all unpaired t tests) derived from sPCs and dPCs reconstructed in Neurolucida. *P < 0.05; **P < 0.01; ***P < 0.001. Optogenetic and chemogenetic manipulations Optogenetic activation of ChR2‐expressing cells in Vip‐Cre;Ai32 slices (Fig. 2A–D ) was achieved using wide‐field blue light (450–510 nm; 10 mW, 10 ms pulses; David & Topolnik, 2017; Magnin et al., 2019) delivered at 30 s intervals through a 40× water‐immersion objective (0.8 NA, Nikon Eclipse FN1). Trains of four stimuli (50 Hz) were used to test the contribution of the GABAB receptors to VIP‐IN‐evoked responses in PCs (Fig. 2E ). Light power was measured at the specimen plane (objective output) and the illuminated field encompassed the recorded soma and surrounding dendritic lamina in RAD. VIP‐INs inhibit both PC types without target‐specificity but with distinct molecular composition of synaptic boutons A, schematic of the experimental design with ChR2‐based light activation of VIP‐INs and recordings from PCs in acute slices from VIP‐Cre;Ai32 mice. B, representative examples of IPSCs evoked in sPCs (blue) and dPCs (brown) by wide‐field light stimulation of VIP‐INs. C, bar graph comparing the connectivity from VIP‐INs to PCs (n = 79 cells, 42 sPCs and 37 dPCs, N = 19 mice: 10F and 9M). D, summary box plots showing IPSCs amplitude (left; n = 29 cells: 15 sPCs and 14 dPCs, N = 12 mice: 7F and 5M; P = 0.682; Wilcoxon's rank test) and area (right, P = 0.411; Wilcoxon's rank test) of VIP‐IN to PC inputs. Grey lines connect cells recorded in the same slice. E, top, representative examples of IPSCs evoked by repetitive light stimulation (4 pulses, 50 Hz) using K‐based high‐Cl− internal solution under control (black) and after subsequent application of CGP‐55845 (red) and picrotoxin (Ptx; blue). Bottom, summary box plot showing changes in IPSC area under control and in the presence of CGP and CGP+Ptx (Ctl vs. CGP: P = 0.689; CGP vs. CGP+Ptx: P = 0.0089; Wilcoxon's rank test). F, representative single‐plane confocal images of the CA1 pyramidal layer immunolabeled for Wfs1 showing the borders for dissociation between the superficial and deep sublayers indicated with dotted lines (left), and high‐magnification images from VIP‐Cre;Ai9 mice showing, from left to right, immunoreactivity for VGAT, VIP, CB1R and their colocalization. G, higher‐magnification confocal images of sPCs and dPCs in CA1 with boutons coexpressing VIP, VGAT and CB1R indicated by arrowheads. H, box plots comparing the density of VIP+/VGAT+ boutons (left; P = 0.7623; Wilcoxon's rank test), VIP+/VGAT+/CB1R+ boutons (middle; P = 0.0019; Wilcoxon's rank test) and VIP+/VGAT+/CB1R– boutons (right; P = 0.0002; Wilcoxon's rank test) in sPCs (blue) and dPCs (brown) in hippocampal sections from VIP‐Cre;Ai9 mice (21 slices/3 mice: 3M). Grey lines connect data values obtained in the same slice. I, box plots comparing the percentage of VIP+/VGAT+/CB1R+ boutons in in sPCs (blue) vs. dPCs (brown) (P = 0.0001; Wilcoxon's rank test). **P < 0.01; ***P < 0.001; ns > 0.05. For chemogenetic silencing of VIP‐INs, pAAV8‐hSyn‐DIO‐hM4Di‐mCherry viral vector (COVF Viral Vector Core, RRID:SCR_016477) was injected bilaterally (500 nL per site) into the dorsal CA1 of VIP‐Cre mice (coordinates from bregma: AP –2.4 mm, ML ±2.4 mm, DV –1.3 mm) as described (Francavilla et al., 2019; Villette et al., 2017). Mice were anaesthetized with either ketamine–xylazine (100 mg/kg and 10 mg/kg, intraperitoneal) or isoflurane (3% for induction in oxygen, ∼0.8–1.5 L/min; 1.5–2% for maintenance in oxygen, ∼0.5 L/min) and placed in a stereotaxic frame (Kopf Instruments). For surgical analgesia and anti‐inflammatory support, mice received a single pre‐operative dose of sustained‐release buprenorphine SR (0.5–1 mg/kg, s.c.). Following surgery, mice received a single dose of carprofen (20 mg/kg, i.p.) and were monitored daily during recovery. Slices were prepared 14–25 days post‐injection. Clozapine‐N‐oxide (CNO; 10 µm; Hello Bio, HB6149) was bath‐applied for ≥15 min following established protocol for VIP‐IN silencing using the same viral construct and recording paradigm (Magnin et al., 2019). Control experiments tested CNO application on slices from non‐injected naïve mice (Fig. 5). For simultaneous optogenetic activation of the SC input and chemogenetic silencing of VIP‐INs, the ChR2 vector (pAAV5‐CaMKIIa‐hChR2(H134R)‐EYFP, 180 nL; COVF Viral Vector Core, RRID:SCR_016477) was injected into the CA3 region (AP –2.4 mm, ML 3.0 mm, DV –2.9 mm), while pAAV8‐hSyn‐DIO‐hM4Di‐mCherry was injected into CA1 of VIP‐Cre mice (Fig. 6A ) as described above. For simultaneous optogenetic activation of the LEC input and chemogenetic silencing of VIP‐INs, the ChR2 vector (pAAV5‐CaMKIIa‐hChR2(H134R)‐EYFP, 180 nL) was injected into the LEC region (AP –3.2 mm, ML 3.8 mm, DV –4.5 mm), while pAAV8‐hSyn‐DIO‐hM4Di‐mCherry was injected into CA1 (Fig. 8A ). Optogenetic stimulation of ChR2‐expressing SC (Fig. 6B ) or LEC (Fig. 8B ) axonal terminals was performed using wide‐field blue light stimulation (450–510 nm; 10 mW, 3 ms pulses) delivered at 30 s intervals through a 40× water‐immersion objective (0.8 NA, Nikon Eclipse FN1), with illumination focused over RAD or SLM for SC and LEC inputs, respectively. Where indicated (Figs 2C,D , 6B , and 8B ), sPCs and dPCs were recorded in the same slice (and, for pathway‐specific optogenetic experiments, simultaneously) to minimize variability in viral expression and stimulation field. Electrophysiological data analysis Electrophysiological data were analysed using Clampfit 10.5 (Molecular Devices) and IgorPro (Wavemetrics). Resting membrane potential (V m) was measured at break‐in and corrected for junction potential (16 mV). Input resistance (R in) and membrane capacitance (C m) were obtained using the membrane test in Clampex. Rheobase was calculated manually based on published criteria (Jarsky et al., 2008; Staff et al., 2000). Current–frequency (I–F) relationship was determined in Clampfit as the number of action potentials per current injection. For postsynaptic potential (PSP) analysis, sweeps with spontaneous activity preceding or overlapping responses were excluded. Remaining sweeps with successful PSP response were averaged to extract PSP traces, which were segmented into EPSP and IPSP components as described in Malik et al., 2022. PSP area was computed in Clampfit as the definite integral between the defined start and end points of corresponding positive (EPSP) or negative (IPSP) component. All electrophysiological analyses were conducted on morphologically identified PCs with confirmed depth location (Fig. 1B ). Immunohistochemistry and morphological analysis To visualize biocytin‐filled cells, slices were fixed overnight in 4% paraformaldehyde and stored in phosphate buffer (PBS) with 0.5 mg/mL sodium azide. Slices were incubated in PBS with 0.25% Triton and 10% normal donkey serum (NDS) for 2 h, followed by overnight incubation at 4°C in PBS with 0.25% Triton, 1% NDS, and Streptavidin‐Alexa‐488 (1:1000, Jackson Immunoresearch). Sections were washed and mounted on slides. Images were acquired using a Leica TCS SP5 laser‐scanning confocal microscope (Z‐stacks: 1 µm step) with a 488 nm laser and 20× (NA 0.8) oil‐immersion objective. A subset of cells was reconstructed using Neurolucida to assess soma and dendritic morphology. Total dendritic length was calculated as the sum of all dendritic branch lengths. Soma and dendritic surface area were computed from the cylindrical segments spanning each structure. For immunohistochemical quantification of VIP+ bouton density in the pyramidal layer (PYR) of CA1 (Fig. 2F–I ), 50 µm coronal hippocampal slices were obtained from Vip‐Cre;Ai9 mice. Mice were perfused with 4% paraformaldehyde containing 20% picric acid in PBS, and brains were post‐fixed for 12 h at 4°C. Fixed tissue was embedded in 4% agar and sliced on a vibratome (50 µm; VT1000; Leica Microsystems), then stored in PB‐sodium azide (0.5 mg/mL). Slices were incubated with combinations of the following primary antibodies: mouse anti‐VGAT (1:500, Millipore, AB2257), rabbit anti‐CB1R (1:500, Alomone Lab, ACR‐001), rabbit anti‐Wfs1 (1:800, Proteintech, 26995‐1‐AP), mouse anti‐calbindin (1:500, Genetex, GTX634833), goat anti‐calretinin (1:1000, Santa Cruz, sc‐11644), rabbit anti‐proCCK (1:500, Frontier Institute, AB_2571674), chicken anti‐GFP (1:1000, Aveslabs, GFP‐1020) and chicken anti‐mCherry (1:500, Aveslabs, AB‐2910557). Secondary antibodies included Alexa Fluor‐conjugated anti‐mouse 488, anti‐goat 488, anti‐rabbit 647 and anti‐chicken 488 or 566 (1:200–1:250). Omission of primary antibodies was used as a control for specific staining. Confocal Z‐stacks (0.25 µm step) were acquired using a Leica TCS SP5 with 20×, or 63× oil‐immersion objectives and 1024 × 1024 or 2048 × 2048 resolution (line average 4–8). Axonal bouton quantification was performed manually, in a single focal plan, by assessing colocalization of VGAT+, VIP+ and CB1R+ signals in x‐y‐z orthogonal projections. Boutons were counted within rectangular regions of interest (20 µm × 100 µm) placed in each PYR sublayer. Experimental design and statistical analysis Experimental group sizes were determined based on previously published studies using similar electrophysiological paradigms (Masurkar et al., 2017; 2020; Bilash et al., 2023), with n denoting the number of recorded cells and N the number of animals. For each experiment, a minimum of 4–7 animals and 6–15 cells per group were included. Immunohistochemical analysis was conducted on 16–25 sections obtained from at least three animals. All experiments included both male and female mice, with sex‐balanced representation whenever possible. No systematic sex differences were observed, and therefore data from both sexes were pooled for final analysis. All datasets were first tested for normality using the Kolmogorov–Smirnov or Shapiro–Wilk test. Depending on the distribution, parametric (paired/unpaired t tests) or non‐parametric (Mann–Whitney or Wilcoxon signed‐rank) statistical tests were used. Because cell numbers per subgroup were modest and response variance increased at high stimulation levels, we prioritized within‐cell comparisons and mixed‐effects models that retain the repeated‐measures structure and avoid inflated degrees of freedom. For input–output analyses, each recorded cell served as its own control. Condition (control vs. CNO) and stimulation intensity (five levels: 1, 1.5, 2, 2.5 and 3) were treated as within‐cell factors. To evaluate whether CNO effects differed between sPCs and dPCs, PC subtype was included as a between‐cell fixed factor, using the model: (1) Responsearea∼Condition*Stimulationintensity*PCsubtype+(1∣AnimalID/CellID) where Cell ID (superficial vs. deep) was specified as a random intercept to account for repeated measurements from the same cell, and Animal ID was included as a random intercept to account for recordings obtained from the same mouse. Stimulation intensity was treated as a categorical factor. Because distributions of synaptic response areas deviated from normality and exhibited heteroscedasticity across stimulation levels, rank‐based repeated‐measures ANOVA (rmANOVA) was used to assess main effects of condition and stimulation intensity, as well as their interaction. Linear mixed‐effects models were then used to test PC subtype‐dependent effects, including the condition × PC subtype and condition × stimulation intensity × PC subtype interactions. In the absence of global condition effects across the full input–output range, depth‐specific comparisons were performed at the maximal stimulation intensity (Stim = 3), where CNO effects were most pronounced (Figs 4D and 7C ). At this stimulation level, paired non‐parametric tests were used for within‐cell comparisons between conditions. To assess depth‐dependent modulation, the change in response area was calculated as: (2) ΔResponsearea=ResponseareaCNO−ResponseareaControl and tested using mixed‐effects models: (3) ΔResponsearea∼PCsubtype+(1∣AnimalID) Statistical analyses were performed in IgorPro or Python, and details are provided in the figure legends. Input–output data are reported as means ± standard deviation, and all single‐dataset data are presented as boxplots showing the individual cell data values, median (horizontal line), mean (red symbol) and standard deviation. Significance levels are indicated as *P < 0.05, **P < 0.01, ***P < 0.001. Results Targeted recordings of sPCs and dPCs in dorsal CA1 hippocampal area To target distinct PC subtypes in mouse dorsal hippocampal CA1 area, we first established criteria to distinguish sPCs and dPCs (Fig. 1). Consistent with earlier findings (Lee et al., 2014), Wolframin‐1 (Wfs1) labelling revealed that the pyramidal layer (PYR) spanned ∼40–60 µm in the dorsal CA1, with calbindin‐positive sPCs occupying roughly half of this width adjacent to the stratum radiatum (RAD; Fig. 1A and C ; n = 25 sections from nine mice). Subsequently, sPCs were recorded within the first 20 µm next to the RAD–PYR border (Fig. 1B and D ), while dPCs were targeted at the stratum oriens border at 40–65 µm from the RAD–PYR border (Fig. 1B and D ). All recorded neurons were filled with biocytin, and the entire study was based on morphologically identified PC types (Fig. 1B ). Consistent with previous studies (Masurkar et al., 2020), analysis of membrane properties confirmed significantly higher intrinsic excitability of dPCs compared with sPCs (Fig. 1E–G ). Specifically, dPCs exhibited higher input resistance, lower rheobase and higher firing frequency (Fig. 1F and G ). In contrast, no differences were observed in resting membrane potential and membrane capacitance (Fig. 1F ) or I h sag amplitude (n = 36 cells, N = 17 mice; P = 0.3249, unpaired t test) between the two PC types. A subset of cells was reconstructed in Neurolucida and processed for detailed morphological analysis, which further confirmed that sPCs had greater dendritic surface area and longer apical dendrites than dPCs, particularly within RAD, while no differences were found in the soma area, or apical dendrite length in SLM (Fig. 1H ). Taken together, these findings are consistent with previous reports (Bannister & Larkman, 1995; Masurkar et al., 2020) and validate sublayer‐specific targeting of PCs in our study. Inhibition of sPCs and dPCs by VIP‐INs To assess connectivity between VIP‐INs and PC subtypes, we optogenetically activated VIP‐INs in slices obtained from VIP‐Cre;Ai32 mice (David & Topolnik, 2017) while recording inhibitory postsynaptic currents (IPSCs) from PCs voltage‐clamped at 0 mV using a Cs‐based internal solution (Fig. 2A and B ). These data showed that both sPCs and dPCs receive direct synaptic input from VIP‐INs (Fig. 2B and C ; n = 15 connected cells out of 42 sPCs tested, and 14 out of 37 dPCs tested). Among connected cells, IPSC amplitude did not differ between PC subtypes, nor did IPSC area (Fig. 2D ). Moreover, no differences in these parameters were found during paired recordings of both PC types in the same slice (Fig. 2D ; grey lines). These findings align with previous reports in rat and mouse hippocampus showing that a small fraction of CCK‐expressing BCs (∼10–16%) coexpress VIP and innervate PCs (Acsády et al., 1996; del Pino et al., 2017; Somogyi et al., 2004; Tyan et al., 2014). Nonetheless, we cannot exclude contributions from non‐basket‐cell subtypes of VIP‐expressing interneurons that directly inhibit PCs, as described in neocortical circuits (Zhou et al., 2017). To test whether direct VIP‐IN activation could recruit both GABAA and GABAB receptor‐mediated response in PCs, we performed additional recordings using K‐based internal solution. With a low‐Cl− K‐based internal solution, light activation of VIP‐INs did not evoke reliable postsynaptic responses in PCs held at −50 mV (n = 30 cells; 13 sPCs/17dPCs, N = 6 mice). We therefore increased the intracellular Cl− concentration to shift ECl to a more depolarized level (−16 mV based on the Nernst equation) and improve detection of GABAA receptor‐mediated currents while maintaining K‐based recording conditions necessary for detecting GABAB receptor‐mediated responses. Under these conditions, detectable responses were observed in 11/33 PCs tested (5/18 sPCs and 6/15 dPCs, N = 9 mice). In these responsive cells, the GABAB receptor antagonist CGP‐55845 did not affect the response, whereas picrotoxin abolished it (Fig. 2E ). Thus, VIP‐IN activation provided the GABAA receptor‐mediated inhibition to PCs under our recording conditions, although these data do not exclude GABAB receptor recruitment under other stimulation regimes or during network states that promote GABA spillover (Jurado‐Parras et al., 2016; Price et al., 2008; Scanziani, 2000; Watson & Booker, 2024). Because VIP‐BCs represent a likely source of direct VIP‐IN‐mediated inhibition onto PCs, we next examined the sub‐layer‐specific distribution of VIP‐expressing (VIP+) synaptic boutons within the PYR, where VIP‐BC axonal terminals are concentrated (Fig. 2F ; Acsády et al., 1996). VIP‐BCs coexpress CCK (Tyan et al., 2014), and CCK‐BCs are characterized by the expression of the CB1R (Katona et al., 1999; Takacs et al., 2015) at their axonal terminals. Because CCK is difficult to detect reliably in axonal boutons, we used CB1R immunolabeling as a molecular marker of a major CCK basket‐cell terminal population. Critically, our analysis focused on VIP+ inhibitory boutons (VIP+/VGAT+), allowing us to quantify the fraction of VIP terminals that coexpress CB1R (VIP+/VGAT+/CB1R+), consistent with a VIP/CCK basket‐cell subset, versus VIP+/VGAT+/CB1R− boutons, which likely reflect distinct VIP‐IN subtypes (Fig. 2F–H ). The results of this analysis revealed no difference in the total density of synaptic VIP+ boutons (Fig. 2H , left), consistent with a similar IPSC amplitude in the two PC subtypes (Fig. 2D ). However, a higher fraction of VIP+/CB1R+ boutons was detected in superficial PYR (Fig. 2H , middle; 2I ). This aligns with previous findings (Valero et al., 2015), suggesting that sPCs predominantly receive CB1R+ boutons, which according to our data can partly originate from VIP+/CCK+ BCs. Conversely, there was a higher density of CB1R‐negative VIP+ boutons in dPCs (Fig. 2H , right), indicating a potential preference for inhibition by a specific subtype of VIP‐BCs that do not express CB1R. Taken together, these data indicate that the VIP‐IN→PC inhibitory channel is compositionally distinct across sPC and dPC subtypes, implying differential cannabinoid modulation of basket‐type VIP outputs. Chemogenetic silencing of VIP‐INs during SC input processing enhances inhibition specifically in dPCs VIP‐INs – particularly the disinhibitory IS‐3 subtype – are strongly driven by SC input and can fire action potentials in response to synchronous activation of as few as 5–7 proximal synapses (Luo et al., 2020). To determine whether they differentially coordinate SC pathway integration in the two PC subtypes, we evoked PSPs by electrically stimulating the RAD using a theta‐glass microelectrode. Consistent with previous findings (Malik et al., 2022), SC‐evoked PSPs exhibited both excitatory (EPSP) and inhibitory (IPSP) components (Figs 3A and 4B,C ). To determine the IPSP reversal potential, we blocked excitatory transmission and recorded the remaining IPSP at different levels of the membrane potential (Fig. 3A ). This analysis revealed similar EGABA values between the two PC types (sPCs: −81.9 ± 1.5 mV, n = 8; dPCs: −79.5 ± 0.7 mV, n = 8). Consequently, to preserve both EPSP and IPSP components, all subsequent recordings were conducted at −70 ± 2.0 mV. Importantly, PSPs remained stable during repetitive stimulation throughout the experimental session (Fig. 3B ), confirming the reliability of our recordings. Control recordings in sPCs and dPCs A, top left, example mean traces of a CA1 PC response to electrical stimulation of RAD in acute hippocampal slices under control conditions (black) and after bath application of glutamate receptor blockers D,L‐AP5 (100 µm) and NBQX (12.5 µm) (red) to isolate IPSPs. Bottom left, summary box plots showing IPSP reversal potential in sPCs (blue) and dPCs (brown; n = 17 cells: 8 sPCs, 8 dPCs, N = 4 mice: 4M; P = 0.1752; unpaired t test). Right, representative traces illustrating IPSP responses at different membrane potential levels in sPCs (blue) and dPCs (brown). B, EPSP area (top; n = 8 cells/N = 4 mice: 1F, 3M; P = 0.9031; paired t test) and IPSP area (bottom; P = 0.2469; paired t test) recorded in PCs in response to repeated RAD stimulation, demonstrating response stability throughout the experiment. Chemogenetic silencing of VIP‐INs reveals their sublayer‐specific role in SC input processing A, representative confocal images showing post hoc immunohistochemical validation of hM4Di‐mCherry expression in the CA1 region of hippocampal slices from a VIP‐Cre mouse injected with pAAV8‐hSyn‐DIO‐hM4Di‐mCherry, targeting both CCK coexpressing (blue; VIP‐BC) and CR coexpressing (green; IS‐3) VIP‐IN subtypes. From left to right: CCK (blue), CR (green), hM4Di‐mCherry (red), and merged images. B, experimental design (schematic, left) and recordings of sPC responses to progressively increasing extracellular RAD stimulation in control (blue) and during chemogenetic inhibition of VIP‐INs via bath application of CNO (10 µm; red, right). C, same as in B, but for dPCs. D, input–output curves for EPSP area (left; n = 14 cells/7 sPCs and 7 dPCs; N = 8 mice: 5F, 3M; condition × stimulus: F(4,52) = 0.294, P = 0.881; rank‐based rmANOVA) and IPSP area (right; condition × stimulus: F(4,52) = 1.0, P = 0.416; rank‐based rmANOVA) in sPCs (blue) and dPCs (brown). Note a trend towards increased IPSP area at higher stimulation intensity in dPCs following VIP‐IN silencing. E, summary data showing EPSP area (left; 7 cells/6 mice: 2F, 4M; P = 0.4688, Wilcoxon's signed test) and IPSP area (right, P = 0.1563, Wilcoxon's signed test) at maximal stimulation intensity before (Ctl) and after CNO application (CNO) in sPCs. F, same as in E, but for dPCs. Note the significant increase in dPC IPSP area at maximal stimulation following chemogenetic silencing of VIP‐INs (right; 7 cells/6 mice: 2F, 4M; P = 0.0156, Wilcoxon's signed test). G, summary of the CNO effect, calculated as the paired difference between CNO and control conditions (ΔCNO–Ctl), for EPSP area (left; Wilcoxon's rank test, P = 0.1439; LMM condition × cell depth interaction: P = 0.21) and IPSP area (right; Wilcoxon's rank test, P = 0.0109; LMM condition × cell depth interaction: P = 0.003). Boxplots show individual data points, with close and far outliers indicated by enlarged circular and rectangular symbols, respectively. The mean is shown as a filled red symbol and the median by a horizontal line. Paired data from the same cell (Ctl vs. CNO) are connected by grey lines. *P < 0.05; **P < 0.01; ns > 0.05. To determine whether VIP‐INs differentially modulate SC input processing in sPCs and dPCs, we combined electrical stimulation of the SC pathway with chemogenetic silencing of VIP‐INs using the inhibitory DREADD hM4Di (Fig. 4A ). hM4Di was expressed in VIP‐INs using our previously established protocol (Magnin et al, 2019), which targets both CCK‐ and CR‐expressing VIP subtypes (Fig. 4A ). In CA1, CR‐expressing IS‐3 cells constitute the predominant VIP‐IN population (Luo et al., 2020; Turi et al., 2019). Bath application of CNO (10 µm) enabled efficient silencing of VIP‐IN activity (see Fig. 5 in Magnin et al, 2019). We analysed SC‐evoked EPSPs and IPSPs by delivering progressively increasing extracellular stimulation intensities through a theta‐glass microelectrode positioned in the RAD under control conditions (Ctl) and in the presence of CNO (Fig. 4B and C ). VIP‐IN silencing did not significantly alter SC‐evoked EPSP input–output relationships in either sPCs or dPCs, indicating that excitatory drive from SC inputs is largely unaffected by VIP‐IN manipulation (Fig. 4D , left). Although a modest trend toward larger EPSPs was observed in sPCs at higher stimulation intensity under CNO, paired comparison at maximal stimulation intensity revealed no significant change in EPSP area (Fig. 4E , left). Consistent with this, linear mixed‐effects modelling (LMM) detected no significant condition (Ctl vs. CNO) × PC subtype interaction (P = 0.21, n = 14 cells/N = 8 mice; Fig. 4G , left). CNO application in naïve slices does not affect SC‐ or TA‐induced responses A, representative mean SC EPSP/IPSP responses evoked by stepwise increases in stimulation intensity (50% increments) recorded under control aCSF conditions (black) and in the presence of CNO (red) in slices from naïve VIP‐Cre mice lacking hM4Di expression. B and C, summary graphs of input–output curves for EPSP area (B; n = 8 cells/ N = 6 mice, 4F, 2M; P = 0.9823, rmANOVA) and IPSP area (C; P = 0.998, rmANOVA). D–F, the same as A–C but for TA input EPSP area (E; n = 6 cells/ N = 3 mice, 2F, 1M; P = 0.9597, rmANOVA) and IPSP area (F; P = 0.6706, rmANOVA). In contrast, VIP‐IN silencing produced a depth‐dependent modulation of inhibitory responses that emerged at high synaptic drive (Fig. 4D , right). At maximal stimulation, IPSP area was significantly increased under CNO in dPCs but not sPCs (Fig. 4E and F ; right), as also reflected by paired ΔCNO–Ctl values (Fig. 4G , right). The LMM analysis incorporating cell depth as a between‐cell factor also confirmed a significant condition × depth interaction (P = 0.003, n = 14 cells/N = 8 mice), indicating that VIP‐IN silencing selectively enhances inhibitory synaptic drive in dPCs. In control slices obtained from naïve mice, CNO application had no effect on either SC EPSPs or IPSPs (Fig. 5A–C ). Together, these results demonstrate that during strong SC activation VIP‐INs selectively reduce inhibition onto dPCs. Because electrical stimulation in the RAD can directly recruit various interneuron types in addition to SC fibres, we next used an optogenetic approach to specifically activate the SC pathway. Channelrhodopsine‐2 (ChR2) fused to eYFP was expressed under the CaMKII promoter in the CA3 area, whereas DREADD hM4Di was expressed in CA1 VIP‐INs, and wide‐field light stimulation was applied in CA1 (Fig. 6A and B ). Light‐evoked SC EPSPs were significantly larger in sPCs than in dPCs (Fig. 6C , left), consistent with the greater dendritic branching (Fig. 1H ) and spine density in sPCs (Masurkar et al., 2017), but also because of a significantly smaller IPSP areas in sPCs (Fig. 6C , right). VIP‐INs disinhibit dPCs during selective activation of SC input A, experimental design (schematic, left) illustrating the viral injection strategy, and representative confocal image (right) showing post hoc validation of eYFP fluorescence in a transverse hippocampal slice from a VIP‐Cre mouse injected in CA3 with a pAAV5‐CaMKIIa‐hChR2(H134R)‐EYFP viral vector and in CA1 with a pAAV8‐hSyn‐DIO‐hM4Di‐mCherry. B, schematic illustrating paired recordings of sPC and dPC responses to optogenetic SC activation simultaneously with chemogenetic inhibition of VIP‐INs via bath application of CNO. C, representative mean traces (top) and summary box plots (bottom) of responses evoked by optogenetic activation of SC input. Shown are EPSP area (left; n = 18 cells: 9 sPCs, 9 dPCs, N = 9 mice: 5F, 4M; P = 0.0006; Wilcoxon's rank test) and IPSP area (right; P = 0.0178; Wilcoxon's rank test). Note the significantly larger SC EPSPs in sPCs and larger IPSPs in dPCs. D, representative mean traces (top) and summary box plots (bottom) comparing sPC responses in control (blue) vs. chemogenetic silencing of VIP‐INs (red; CNO 10 µm bath application) during SC photoactivation. Shown are EPSP area (left; n = 9 cells, N = 3 mice: 2F, 1M; P = 0.1289; Wilcoxon's signed test) and IPSP area (right; P = 0.6523; Wilcoxon's signed test). E, same as in D, but for dPCs in control (brown) vs. VIP‐IN silencing (red). Summary data show EPSP area (n = 7 cells, N = 6 mice: 3F, 3M; P = 0.0156; Wilcoxon's signed test) and IPSP area (P = 0.0226; paired t test). Note the significant decrease in dPC EPSP area in parallel with an increase in IPSP area when VIP‐INs were inhibited. Boxplots display individual cell values, with far outliers indicated by enlarged rectangular symbols. The mean is represented by a filled red symbol and the median by a horizontal line. Paired measurements from the same cell are connected by grey lines. *P < 0.05; ***P < 0.001; ns > 0.05. Simultaneous chemogenetic silencing of VIP‐INs (Fig. 6B ) had no significant effect on either EPSPs or IPSPs evoked by optogenetic SC activation in sPCs (Fig. 6D ). In contrast, silencing VIP‐INs during light activation of SC inputs in dPCs consistently reduced EPSP and increased IPSP area (Fig. 6E ). Together, these findings confirm the effects seen with electrical stimulation and demonstrate a sublayer‐specific function of VIP‐INs in regulating the SC input processing, with disinhibitory control confined to dPCs. Sublayer‐specific effects of chemogenetic VIP‐IN silencing during TA input processing TA input robustly recruits VIP‐INs, with as few as 4–5 distal synapses sufficient to elicit somatic spiking (Luo et al., 2020). To determine how VIP‐INs regulate TA pathway processing across the two PC subtypes, we assessed the effects of chemogenetic VIP‐IN silencing on EPSPs and IPSPs evoked by electrical stimulation in the SLM (Fig. 7A and B ). CNO application in naïve slices had no effect on either TA‐evoked EPSPs of IPSPs (Fig. 5D–F ). In contrast, in slices expressing the inhibitory DREADD hM4Di, CNO application resulted in depth‐specific modulation of both EPSPs and IPSPs, with a trend toward larger EPSPs in sPCs and stronger IPSPs in dPCs across the input–output curve, particularly at higher stimulation intensities (Fig. 7C ). Sublayer‐specific role of VIP‐INs in TA input processing A, experimental design (schematic, left) and recordings of sPC responses to progressively increasing extracellular SLM stimulation in control (blue) and during chemogenetic inhibition of VIP‐INs via bath application of CNO (red; right). B, same as in A, but for dPCs. C, input–output curves for EPSP area (left; n = 13 cells/7 sPCs and 6 dPCs; N = 10 mice: 6F, 4M; condition × stimulus: F(4,48) = 0.45, P = 0.77; rank‐based rmANOVA) and IPSP area (right; condition × stimulus: F(4,48) = 2.94, P = 0.11; rank‐based rmANOVA) in sPCs (blue) and dPCs (brown). Note trends toward the increased EPSP area in sPCs and IPSP area in dPCs at higher stimulation intensity following VIP‐IN silencing. D, summary data showing EPSP area (left; 7 cells/6 mice: 3F, 3M; P = 0.0469, Wilcoxon's signed test) and IPSP area (right, P = 0.4688, Wilcoxon's signed test) at maximal stimulation intensity before (Ctl) and after CNO application (CNO) in sPCs. E, same as in D, but for dPCs. Note the significant increase in dPC IPSP area at maximal stimulation following chemogenetic silencing of VIP‐INs (right; 6 cells/4 mice; P = 0.0313, Wilcoxon's signed test). F, summary of the CNO effect, calculated as the paired difference between CNO and control conditions (ΔCNO–Ctl), for EPSP area (left; Wilcoxon's rank test, P = 0.0056; LMM condition × cell depth interaction: P = 0.003) and IPSP area (right; Wilcoxon's rank test, P = 0.103; LMM condition × cell depth interaction: P = 0.035). Boxplots show individual data points, with far outliers indicated by enlarged rectangular symbols. The mean is shown as a filled red symbol and the median by a horizontal line. Paired data from the same cell (Ctl vs. CNO) are connected by grey lines. *P < 0.05; **P < 0.01; ns > 0.05. In line with these intensity‐dependent trends, in sPCs VIP‐IN silencing at maximal stimulation intensity had no impact on IPSPs but significantly increased EPSP area (Fig. 7D ), as also reflected by paired ΔCNO–Ctl values (Fig. 7F ). This effect is consistent with removal of shunting inhibition, likely mediated by VIP/CCK‐coexpressing BCs that preferentially target sPCs (Fig. 2H ). The LMM analysis with cell depth as a between‐cell factor further confirmed a significant condition (Ctl vs. CNO) × depth interaction (P = 0.003, n = 13 cells/N = 10 mice), indicating that VIP‐IN activity results in preferential reduction of TA‐evoked EPSPs in sPCs. In contrast, dPCs exhibited unaltered TA‐evoked EPSPs but larger IPSPs during VIP‐IN silencing at maximal stimulation intensity (Fig. 7E ). LMM analysis at maximal stimulation revealed significant main effects of condition, (Ctl vs. CNO, P = 0.001; n = 13 cells/N = 10 mice) and condition × depth interaction (P = 0.035; Fig. 7F , right), indicating that VIP‐INs provide a stronger disinhibition to dPCs than to sPCs during TA input processing. VIP‐INs, particularly IS class, are strongly recruited by the LEC component of the TA pathway, which can promote dendritic spike generation in PCs through distal dendritic disinhibition (Bilash et al., 2023). To determine whether VIP‐IN silencing differentially regulates LEC input processing in the two PC subtypes, we next used an optogenetic strategy to selectively activate LEC afferents in the CA1. ChR2‐eYFP was expressed under the CaMKII promoter in the LEC area, whereas DREADD hM4Di was expressed in CA1 VIP‐INs (Fig. 8A ). Wide‐field photostimulation was delivered to SLM in distal CA1 (Masurkar et al., 2017) under control condition and during chemogenetic silencing of CA1 VIP‐INs (Fig. 8B ). Light‐evoked TA EPSPs and IPSPs were both significantly larger in sPCs than in dPCs (Fig. 8C , left). Concurrent chemogenetic silencing of VIP‐INs resulted in a significant reduction of LEC EPSP area and markedly increased IPSP area in sPCs (Fig. 8D ). In contrast, VIP‐IN silencing did not affect EPSPs but increased IPSP area during LEC input processing in dPCs (Fig. 8E ). Together, these findings reveal a shared disinhibitory role of VIP‐INs during LEC input processing across PC subtypes, with a stronger net impact in sPCs, where enhanced inhibition during VIP‐IN silencing leads to partial shunting of excitatory responses. VIP‐INs disinhibit both PC subtypes during selective activation of LEC input A, experimental design (schematic, left) illustrating the viral injection strategy, and representative confocal image (right) showing post hoc validation of eYFP fluorescence in a transverse hippocampal slice from a VIP‐Cre mouse injected in LEC with a pAAV5‐CaMKIIa‐hChR2(H134R)‐EYFP viral vector and in CA1 with a pAAV8‐hSyn‐DIO‐hM4Di‐mCherry. B, schematic illustrating paired recordings of sPC and dPC responses to optogenetic LEC activation simultaneously with chemogenetic inhibition of VIP‐INs via bath application of CNO. C, representative mean traces (top) and summary box plots (bottom) of responses evoked by optogenetic activation of LEC input. Shown are EPSP area (left; n = 14 cells: 6 sPCs, 8 dPCs, N = 5 mice: 4F, 1M; P = 0.0053; Wilcoxon's rank test) and IPSP area (right; P = 0.0123; Wilcoxon's rank test). Note the significantly larger LEC EPSPs and IPSPs in sPCs. D, representative mean traces (top) and summary box plots (bottom) comparing sPC responses in control (blue) vs. chemogenetic silencing of VIP‐INs (red) during LEC photoactivation. Shown are EPSP area (left; P = 0.0313; Wilcoxon's signed test) and IPSP area (right; P = 0.03125; Wilcoxon's signed test). E, same as in D, but for dPCs in control (brown) vs. VIP‐IN silencing (red). Summary data show EPSP area (P = 0.8438; Wilcoxon's signed test) and IPSP area (P = 0.0078; Wilcoxon's signed test). Note the significant increase in dPC IPSP area when VIP‐INs were inhibited. Boxplots display individual cell values, with close and far outliers indicated by enlarged circular and rectangular symbols, respectively. The mean is represented by a filled red symbol and the median by a horizontal line. Paired measurements from the same cell are connected by grey lines. *P < 0.05; **P < 0.01; ns > 0.05. Discussion We show that VIP‐INs regulate CA1 excitability in a sublayer‐ and pathway‐specific manner, indicating that VIP‐IN signalling is embedded in distinct inhibitory motifs associated with sPC and dPC subnetworks. While VIP‐INs are frequently discussed as disinhibitory ‘gatekeepers’, our results support a dual role in CA1: VIP‐INs can provide direct perisomatic inhibition to PCs and, depending on the recruited subtype, simultaneously drive disinhibition through interneuron‐selective targeting. This duality is consistent with established CA1 VIP subtype wiring, in which IS cells (such as IS‐2 and IS‐3) preferentially inhibit interneurons, whereas VIP‐BCs directly inhibit PCs and are not connected to interneurons in the same manner (Acsády et al., 1996; Tyan et al., 2014). Our optogenetic mapping confirms that both sPCs and dPCs receive direct inhibitory input from VIP‐INs, consistent with the presence of VIP‐positive BC inputs onto PC population (Tyan et al., 2014). However, synaptic bouton‐level analysis suggests that the perisomatic VIP inhibitory ‘channel’ may not be identical across sublayers, because the superficial pyramidal layer contains a higher fraction of VIP+/CB1R+ boutons, whereas dPCs show a relatively higher density of VIP+/CB1R− boutons. This pattern aligns with known sublayer‐specific perisomatic inhibition in CA1, in which PV basket‐cell inputs preferentially target dPCs while cannabinoid‐sensitive (CB1R+) basket‐cell inputs are enriched in superficial compartments (Lee et al., 2014; Valero et al., 2015). However, paired‐recording work indicates that, unlike PV‐BCs, CCK‐BCs do not show strong deep–superficial target selectivity (Lee et al., 2014), suggesting that differences in CB1R bouton distributions across studies may reflect differences in terminal composition, receptor expression or sampling rather than a simple change in unitary inhibitory strength. Together, these observations support the interpretation that VIP‐IN‐mediated direct inhibition is positioned to shape sPC and dPC outputs through partially distinct perisomatic inhibitory synapse populations. In the SC pathway, chemogenetic silencing of VIP‐INs selectively increased inhibition onto dPCs during strong synaptic drive, with comparatively weaker effects in sPCs. This depth dependence fits well with the established deep > superficial bias in PV‐IN‐mediated inhibition, which produces stronger feedforward inhibitory control of CA3‐driven excitation in dPCs (Lee et al., 2014). Notably, recent work has provided a developmental basis for this circuit asymmetry by showing that SATB2 expression in sPCs suppresses PV‐IN synapse formation during synaptogenesis, thereby establishing the mature deep‐biased feedforward inhibitory motif (Hanson et al., 2025). Within this context, our findings identify VIP‐INs as a candidate mechanism for dynamically modulating this deep‐biased feedforward inhibitory scaffold. Because VIP IS cells can fire spikes in response to SC activation, VIP‐IN recruitment during strong CA3 drive could suppress the interneuron populations that provide dominant inhibition to dPCs, effectively shifting the excitation–inhibition ratio in favour of deep‐layer output (Luo et al., 2020). The functional consequence of preferential VIP‐IN‐dependent disinhibition of dPCs is particularly relevant given the well‐documented physiological and coding differences between deep and superficial CA1 populations. Deep CA1 PCs tend to fire at higher rates, burst more, and are more likely to express place fields than sPCs, and multiple studies suggest that superficial populations can provide more stable contextual representations whereas deep populations are more flexible and shaped by learning about salient features (Danielson et al., 2016; Geiller et al., 2017; Mizuseki et al., 2011; Sharif et al., 2021). We therefore propose that VIP‐INs may contribute to balancing stable versus flexible CA1 output streams by selectively reducing deep‐layer inhibitory gain during conditions of strong intrahippocampal drive. In contrast to the SC pathway, TA pathway stimulation revealed VIP‐IN‐dependent modulation of both excitation and inhibition that differed across depth. VIP‐IN silencing increased TA EPSP area in sPCs, consistent with removal of a shunting inhibitory component, while inhibitory responses were also modulated in a depth‐sensitive fashion at high stimulation intensities. These effects suggest that TA engages VIP‐IN‐dependent control over both perisomatic and dendritic inhibitory gates, with the net physiological outcome determined by which inhibitory circuits are most strongly recruited in each sublayer. This view is supported by emerging evidence that dendrite‐targeting interneuron circuits themselves differ across the CA1 radial axis: sPCs can receive stronger proximal‐dendritic inhibition from somatostatin‐expressing interneurons, whereas a Chrna2‐Cre–defined OLM subset can provide stronger distal dendritic inhibition onto dPCs (Johantges et al., 2025). In this framework, VIP‐IN‐mediated inhibition of interneuron populations could reallocate inhibition across compartments (proximal vs. distal dendrites, soma vs. dendrite) in sublayer‐specific ways during TA input processing. Furthermore, our optogenetic LEC experiments provide an important pathway‐specific extension of these findings to a physiologically defined cortical input. LEC inputs directly drive CA1 distal dendrites and can promote dendritic spike generation via recruitment of a local VIP disinhibitory microcircuit, while simultaneously recruiting CCK interneurons that can suppress dendritic spikes (Bilash et al., 2023). We observed that optogenetic LEC activation evokes larger EPSPs and IPSPs in sPCs than in dPCs, consistent with established sublayer bias in entorhinal–CA1 connectivity in which LEC preferentially excites sPCs in distal CA1, a pattern linked to dendritic spine number and dendritic integration rules (Masurkar et al., 2017). Importantly, VIP‐IN silencing markedly increased IPSP area in both PC types and selectively reduced EPSP area in sPCs. These results are consistent with a model in which VIP‐INs normally constrain the inhibitory gain recruited by LEC input (i.e. provide disinhibition), thereby permitting stronger effective excitation, particularly in sPCs, where LEC drive is strongest (Masurkar et al., 2017). In other words, the stronger net effect of VIP‐IN silencing in sPCs suggests that sPCs operate in a regime where VIP‐IN‐dependent dendritic disinhibition is most critical for preserving the impact of LEC excitation against concurrently recruited inhibition. One limitation is that the interneuron populations mediating the increased inhibition observed after VIP‐IN silencing were not directly identified. Based on known CA1 VIP‐IN wiring, dendrite‐targeting interneurons, including SST/OLM cells, are strong candidates. However, because our manipulations targeted the broader VIP‐IN population, including IS‐3, IS‐2 and VIP‐BC‐related circuits, the observed effects likely reflect the combined recruitment of multiple VIP‐sensitive inhibitory motifs. Future experiments using subtype‐specific VIP‐IN and postsynaptic interneuron targeting will be required to resolve the precise circuit elements recruited by SC versus TA/LEC pathways. Taken together, our data indicate that VIP‐INs do not act as uniform modulators of CA1 excitability. Instead, VIP‐IN‐dependent control is routed through sublayer‐specific inhibitory microcircuits whose composition and recruitment depend on the active input pathway. In the SC pathway, VIP‐INs preferentially lower inhibitory gain on dPCs during strong intrahippocampal drive, consistent with a dynamic, state‐dependent ‘release’ of dPCs from PV‐IN‐dominated inhibition. In the TA/LEC pathway, VIP‐INs shape the balance of excitation and inhibition during distal cortical input, consistent with VIP‐IN‐dependent gating of dendritic excitability mechanisms implicated in nonlinear dendritic computations (Bilash et al., 2023). A final implication concerns behavioural state. VIP IS populations can be recruited by both SC and TA pathway activation and show network‐state‐dependent engagement in vivo (Luo et al., 2020), suggesting that VIP‐dependent circuit reweighting may be particularly relevant during theta‐associated exploration and learning conditions. In addition, CA1 VIP‐INs display strong activity increases during novelty and contribute to novelty encoding and recognition memory, supporting a broader role for VIP‐IN‐dependent disinhibition in enabling rapid reconfiguration of hippocampal representations (Neubrandt et al., 2025; Tamboli et al., 2024). In this light, the sublayer‐ and pathway‐specific VIP microcircuits described here may provide a mechanistic substrate for selectively opening and closing plasticity‐ and integration‐favourable windows in distinct CA1 input channels during changes in behavioural context. Additional information Competing interests The authors declare no competing financial interests. Author contributions The study was conducted in the laboratory of L.T. at Université Laval. P.I. and J.G. contributed equally to the acquisition, analysis and interpretation of the data. F.V. contributed to data acquisition for Fig. 2. P.I. and J.G. prepared the initial draft of the manuscript. L.T. conceived and designed the study, acquired funding and contributed to data analysis and interpretation and to the critical revision of the manuscript. All authors approved the final version of the manuscript, agree to be accountable for all aspects of the work, and will ensure that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All authors qualify for authorship, and all individuals who qualify for authorship are listed. Funding This work was supported by the Canadian Institutes of Health Research (CIHR grant nos. MOP‐137072 and MOP‐142447), and the Natural Sciences and Engineering Research Council of Canada (NSERC grant no. 342292‐2012) to L.T. P.I. was supported by the PhD fellowships from the NeuroQuébec and FRQS. Generative AI statement No generative AI tools were used in the preparation of this manuscript. Supporting information Peer Review History